Expansion of Production Facilities and Strengthening of R&D Capabilities
First written in FY2024. 6 of 7 entries say "Advanced", first in FY2025-H1. Latest entry: 2026-08-25.
The whole theme swung hardest in 2024: 1 of 7 companies on the "Worse" side.
4 other companies' latest entry also says "Advanced".
- 2026-08-25AdvancedOther Disclosures
「新工場は、細胞培養用培地の安定供給体制の強化及び中長期的な成長戦略の推進を目的として、2030 年の稼働を予定しております。」
生産能力の拡充と安定供給体制の強化を目的とする新工場について、2030年の稼働予定、細胞培養用培地の開発・製造・販売、雇用計画42名が示された。 - FY2026AdvancedAnnual report
「Total capital investment for the consolidated fiscal year was ¥1,043 million. Major items included the remaining construction costs for the warehouse and staff break room and changing room facilities, construction work and installed equipment for the cell processing facility scheduled to be newly established on the fifth floor of the warehouse, and land acquired in Nagasaki Prefecture for construction of a new plant.」
To strengthen production facilities and research and development functions, the company proceeded with the construction of a warehouse and related facilities, the development of a cell-processing facility, and the acquisition of factory land in Nagasaki Prefecture. - 2026-05-15AdvancedRevision of earnings forecasts
「これは主に、土地の取得及び新倉庫の完成により有形固定資産が544百万円増加したこと、及び投資有価証券が79百万円増加したことにより投資その他の資産が100百万円増加したことによるものであります。」
土地取得と新倉庫完成による固定資産増加を通期実績として記載している。 - FY2026-H1AdvancedAnnual report
「During the interim consolidated accounting period, the following major capital expenditure projects that had been planned at the end of the previous consolidated fiscal year were completed.」
To enhance production and business infrastructure, the planned head-office warehouse and employee break and changing-room facilities were completed, with total investment of ¥1,016 million and completion in September 2025. - FY2025AdvancedAnnual report
「Capital expenditures for the fiscal year totaled ¥1,049 million, primarily for the construction of a warehouse and employee break and changing-room facilities, and the installation of a mass spectrometer for research purposes.」
To strengthen production facilities and research and development functions, actual capital expenditures for the full year totaled ¥1,049 million, including construction of a warehouse and related facilities and the installation of a mass spectrometer. - FY2025-H1AdvancedAnnual report
「Increase in warehouse capacity of approximately 1,600 m²」
A plan has been presented for the construction of a warehouse and employee break and changing-room facilities at the head office, with planned investment of ¥1,072 million, construction starting in May 2024, completion scheduled for June 2025, and warehouse capacity increasing by approximately 1,600 m². - FY2024First statedAnnual report
「Capital expenditure totaled ¥726 million in the current consolidated fiscal year, primarily for manufacturing equipment for immunochromatographic antigen test kits and the replacement of high-voltage power receiving equipment at the Sakado Head Office Plant.」
Investment in production facilities, research and development functions, disaster-response facilities and other areas remains ongoing.